Company Profiles

driven by the PitchBook Platform

Focal Therapeutics

Description

Developer and manufacturer of novel tissue-marking devices for use in surgery designed to mark the surgical site of tissue removal in 3D. The company's BioZorb marker is an implantable device, placed by surgeons into the surgical site of tissue removal enabling them to overcome challenges involved in identifying the tissue excision site for subsequent medical procedures and/or follow-up imaging.

2007

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$48.9k

Latest Deal Amount

$15.2M

Total Amount Raised

Description

Developer and manufacturer of novel tissue-marking devices for use in surgery designed to mark the surgical site of tissue removal in 3D. The company's BioZorb marker is an implantable device, placed by surgeons into the surgical site of tissue removal enabling them to overcome challenges involved in identifying the tissue excision site for subsequent medical procedures and/or follow-up imaging.

Website:

www.focalrx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Primary Office

30 Enterprise Suite 220 Aliso Viejo, CA 92656United States +1 (855) 764-7258
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Focal Therapeutics's full profile, request a free trial.

    Focal Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Focal Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Focal Therapeutics Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Emergent Medical PartnersVenture CapitalMinority000 0000000 0000
    Okapi Venture CapitalVenture CapitalMinority000 0000000 0000
    Emergent Medical Partners Venture Capital
    Okapi Venture Capital Venture Capital

    Focal Therapeutics Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Steven GexChief Executive Officer & Board Member
    George HermannPresident & Board Member
    Steven NaberChief Financial Officer
    Brian DriscollVice President, Marketing
    Daniel BeneyVice President, Sales
    Steven Gex Chief Executive Officer & Board Member
    George Hermann President & Board Member
    Steven Naber Chief Financial Officer
    Brian Driscoll Vice President, Marketing
    Daniel Beney Vice President, Sales

    Focal Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Gail Lebovic MDFocal TherapeuticsChief Medical Officer & Board Member000 0000
    George HermannFocal TherapeuticsPresident & Board Member000 0000
    Robert Brownell JDEmergent Medical PartnersManaging Director000 0000
    Sharon Stevenson Ph.DOkapi Venture CapitalCo-Founder & Managing Director000 0000
    Steven GexFocal TherapeuticsChief Executive Officer & Board Member000 0000
    Gail Lebovic MD Chief Medical Officer & Board Member Focal Therapeutics
    George Hermann President & Board Member Focal Therapeutics
    Robert Brownell JD Managing Director Emergent Medical Partners
    Sharon Stevenson Ph.D Co-Founder & Managing Director Okapi Venture Capital
    Steven Gex Chief Executive Officer & Board Member Focal Therapeutics
    Request full access to PitchBook